Dasetta 1/35 Kit
Product Images NDC 16714-348

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Dasetta 1/35 (NDC 16714-348). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 01

Image 01
Chemical structures of the active ingredients norethindrone and ethinyl estradiol, shown as two distinct steroidal molecular diagrams with labeled names beneath each structure.*
FDA Label Image

Image 02

Image 02
A bar chart showing circulatory disease mortality rates per 100,000 woman-years categorized by age group, smoking status, and oral contraceptive use. The chart compares mortality rates for ever users and controls among non-smokers and smokers across four age ranges: 15-24, 25-34, 35-44, and 45 and older.*
FDA Label Image

Image 03

Image 03
A drug warning text panel for Dasetta 1/35 (Norethindrone and Ethinyl Estradiol), advising not to use the product if smoking cigarettes and over 35 years old due to increased risk of serious cardiovascular side effects, including heart attack, blood clots, or stroke. The risk is noted to increase with age and cigarette consumption.*
FDA Label Image

Image 04

Image 04
Dasetta 1/35 kit containing oral tablets of Norethindrone and Ethinyl Estradiol. The horizontal blister pack is organized by day of the week with color-coded tablets: three rows of orange tablets followed by one row of white tablets. The right side displays product identification including labeler Northstar Rx LLC and product NDC 16714-348.*
FDA Label Image

Image 05

Image 05
An instructional diagram illustrating how to pick the correct day label for a Dasetta 1/35 oral tablet kit. The image shows a hand peeling a day-of-the-week label strip and placing it on the medication blister pack, aligning with the days printed above the tablets, which are arranged in rows by week with orange and white tablets.*
FDA Label Image

Image 06

Image 06
A boxed warning or precaution text panel for Dasetta 1/35 oral kit, advising that individuals who smoke cigarettes and are over 35 years old should not use this product due to increased risk of serious cardiovascular side effects including heart attack, blood clots, or stroke. The risk is stated to increase with age and the number of cigarettes smoked.*
FDA Label Image

Image 07

Image 07
Dasetta 1/35 oral kit packaging label showing a 28-day blister card with pills arranged by day of the week (Sunday to Saturday). The blister contains three rows of orange pills and one row of white pills, each labeled with descriptors such as "Start Orange Pill" and "Take one pill daily." The right side of the card displays the product name, active ingredients (Norethindrone and Ethinyl Estradiol), and labeler Northstar Rx LLC.*
FDA Label Image

Image 08

Image 08
An instructional illustration showing how to apply a day label to a Dasetta 1/35 oral contraceptive pill kit. A hand is depicted peeling and placing a day-of-the-week label to align with the medication slots in the pill pack.*
FDA Label Image

Image 09

FDA Label Image

Image 10

Image 10
Dasetta 1/35 kit containing Norethindrone and Ethinyl Estradiol Tablets, USP, 1 mg/0.035 mg oral dosage form. The package is labeled as a 28-day regimen with six blister cards of 28 tablets each. The labeler is Northstar Rx LLC. The design includes purple text and a flower graphic. The package also includes barcode and prescription-only markings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.